Skip to content
Lower risk Drug recall · FDA · Published July 13, 2020

Fresenius Kabi Fosaprepitant Injection Recall: Labeling Error in EDTA Quantity

Fresenius Kabi recalls Fosaprepitant injection vials with incorrect EDTA labeling. This labeling error may affect medication accuracy. Affected vials have specific NDC and lot numbers. Contact for details.

🇺🇸 FDA recall #D-1391-2020DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
✎ GovInfoNow plain-language explainer

Fresenius Kabi is recalling certain Fosaprepitant injection vials due to a labeling error that incorrectly states the amount of EDTA. This error could lead to inaccurate medication dosing if the vial is used without correction. Read more at govinfonow.com/recall/36935-fresenius-kabi-fosaprepitant-injection-recall-labeling-error-in-edta-quantity.

Source Summary by GovInfoNow · govinfonow.com/recall/36935-fresenius-kabi-fosaprepitant-injection-recall-labeling-error-in-edta-quantity · Updated October 5, 2026 · FDA enforcement record: FDA #D-1391-2020

Cite this page

“Fresenius Kabi Fosaprepitant Injection Recall: Labeling Error in EDTA Quantity.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36935-fresenius-kabi-fosaprepitant-injection-recall-labeling-error-in-edta-quantity. Based on FDA recall #D-1391-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1391-2020%22&limit=1).

Fresenius Kabi USA, LLC voluntarily recalled Fosaprepitant for Injection due to a labeling error stating an incorrect quantity of edetate disodium, according to the FDA on July 13, 2020.

How to tell if you have it

  • Brand: Fresenius Kabi
  • Product: Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial
  • NDC: 63323-972-10
  • Lot codes: 6122760 (exp 08/2021), 6122761 (exp 08/2021), 6122762 (exp 09/2021), 6123883 (exp 03/2022)
  • Units: 63,067 vials

The hazard

The carton label and product insert incorrectly state the quantity of the excipient edetate disodium as 5.4 mg / vial instead of the actual amount of 18.8 mg / vial.

Context

GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Other recent recalls include a Tyenne Injection recall for glass particles (August 10, 2026), Morphine Syringes with wrong labeling (August 4, 2026), and Lidocaine HCl Injection with hair found in products (July 16, 2026). Other recent recalls of similar products include an American Regent Levocarnitine Injection recall for a missing label (April 16, 2026), a Slate Run Eptifibatide Injection recall due to labeling error (February 12, 2026), and an Otsuka ICU Medical Potassium Chloride Inj. 20mEq Label Error Recall (October 29, 2025).

How to tell if you have this one

Check for vials with NDC 63323-972-10, lot numbers 6122760, 6122761 (exp 08/2021), 6122762 (exp 09/2021), or 6123883 (exp 03/2022). These vials are labeled with incorrect EDTA quantities.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Label

    Verify the EDTA quantity on the label; if it shows 5.4 mg instead of 18.8 mg, this vial is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.1 years after the firm started it.

1. Firm started the recall: Jul 13, 202012. FDA classified it Class III: Jul 16, 202023. Published in FDA’s Enforcement Report: Jul 22, 202034. FDA terminated the recall: Aug 19, 2022420202022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1391-2020 (July 13, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1391-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA